lm 4108 has been researched along with Arteriosclerosis in 1 studies
indomethacin phenethylamide: a cyclooxygenase-2 inhibitor; structure in first source
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burleigh, ME | 1 |
| Babaev, VR | 1 |
| Patel, MB | 1 |
| Crews, BC | 1 |
| Remmel, RP | 1 |
| Morrow, JD | 1 |
| Oates, JA | 1 |
| Marnett, LJ | 1 |
| Fazio, S | 1 |
| Linton, MF | 1 |
1 other study available for lm 4108 and Arteriosclerosis
| Article | Year |
|---|---|
Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycloox | 2005 |